China's Harbin Pharma to buy stake in U.S. health retailer GNC

HONG KONG, Feb 14 (Reuters) - China's state-controlled drugmaker Harbin Pharmaceutical Group Holding Co will buy an about 40 percent stake in U.S. nutritional supplements retailer GNC Holdings Inc for $300 million and are in talks for a joint venture in China, the companies said.